Monitoring
Monitoring bronchiectasis may include sputum culture, oxygen saturation measurement (SpO2), and Medical Research Counsil (MRC) dyspnea score. For mild disease, follow-up is annual while for moderate-severe disease follow-up is every 6 months. Annual spirometry and body mass index (BMI) measurement may be done. While CT scan is indicated for patients with clinical deterioration or every 5 years for patients with primary immunodeficiency. Follow-up also includes regular monitoring and management of complications and comorbidities. Treating possible complications and/or comorbidities such as nutritional deficiencies, GERD/aspiration, asthma, COPD, ABPA and other pathogens, odontogenic and otorhinolaryngeal disorders, urinary incontinence, anxiety and mental health disorders is also important. Lastly, some patients may also require assessments for sleep-disordered breathing and cardiac complications.